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Directed Evolution of Epoxide Hydrolase from
A. radiobacter toward Higher Enantioselectivity
by Error-Prone PCR and DNA Shuffling
Chiral epoxides and diols are important building
blocks for the preparation of enantiopure pharmaceuti-
cals and other fine chemicals. For example, styrene ox-
ide derivatives (epoxides 1–3, Figure 1) and phenyl glyci-
dyl ethers (4 and 5) can be used in the synthesis of
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Biotechnology Institute -adrenergic agonists by ring opening of the chiral epox-
ide with an amine [7–9]. Epichlorohydrin (6, Figure 1)University of Groningen
Nijenborgh 4 can be used in the synthesis of food additives [10],
antibacterial agents [11], and pharmaceuticals [12]. In9747 AG Groningen
2DSM Pharma Chemicals these examples, the epoxide is mainly used in a nucleo-
philic ring-opening reaction that occurs with retentionAdvanced Synthesis, Catalysis & Development
P.O. Box 18 of configuration around the chiral center of the epoxide.
It is therefore important to start the conversion with6160 MD Geleen
The Netherlands enantiopure epoxide. Existing methods for preparing
enantiopure epoxides and vicinal diols include asym-
metric synthesis, which can be done by epoxidation of
a carbon-carbon double bond using chiral metalosalenSummary
complexes [13] or monooxygenases [14], and kinetic
resolution of a racemic epoxide, using a Jacobsen cata-The enantioselectivity of epoxide hydrolase from Agro-
lyst [15] or an epoxide hydrolase [16].bacterium radiobacter (EchA) was improved using er-
Several epoxide hydrolases are enantioselective andror-prone PCR and DNA shuffling. An agar plate assay
have been tested in kinetic resolutions to obtain an en-was used to screen the mutant libraries for activity.
antiopure epoxide and an optically active diol with theScreening for improved enantioselectivity was subse-
opposite stereochemistry at the chiral center [16]. Thequently done by spectrophotometric progress curve
yield of the remaining substrate and the enantiopurityanalysis of the conversion of para-nitrophenyl glycidyl
of the diol are often not very high due to the low enantio-ether (pNPGE). Kinetic resolutions showed that eight
selectivity of the enzyme. Therefore, it is desirable tomutants were obtained with up to 13-fold improved
improve the enantioselectivity of epoxide hydrolases,enantioselectivity toward pNPGE and at least three
which so far has been described for the enzymes fromother epoxides. The large enhancements in enantio-
Agrobacterium radiobacter [5, 17] and Aspergillus nigerselectivity toward epichlorohydrin and 1,2-epoxyhex-
[18]. With A. radiobacter epoxide hydrolase, rational de-ane indicated that pNPGE acts as an epoxyalkane
sign using site-directed mutagenesis of the ring-open-mimic. Active site mutations were found in all shuffled
ing tyrosines resulted in 2- to 5-fold improved enantio-mutants, which can be explained by an interaction of
selectivity toward a number of aromatic epoxides [5, 17,the affected amino acid with the epoxide oxygen or
19]. The enantioselectivity of the epoxide hydrolase fromthe hydrophobic moiety of the substrate. Several mu-
A. niger toward phenyl glycidyl ether was recently 2-foldtations in the shuffled mutants had additive effects.
improved by random mutagenesis [18], but the enantio-
selectivity of the best mutant (E  10.8) was not higher
Introduction than that of the A. radiobacter wild-type enzyme (E 
11) [17].
Epoxide hydrolases (E.C. 3.3.2.3) catalyze the net addi- In this paper, we report the use of directed evolution
tion of a water molecule to an epoxide, resulting in a for improving the enantioselectivity of the epoxide hy-
vicinal diol as the sole product. So far, all epoxide hy- drolase from A. radiobacter (EchA). Since this approach
drolases for which the gene has been cloned, except uses large libraries of mutants, rapid methods for
for one [1], are members of the/-hydrolase fold family. screening the activity and enantioselectivity are desir-
These enzymes share a main domain consisting of a able. An agar plate assay for epoxide hydrolase activity,
central  sheet surrounded by  helices, with a variable which uses the oxidative power of Escherichia coli
cap domain sitting on top [2]. The active site of epoxide toward vicinal diols that are produced by epoxide hydro-
hydrolases is located at the interface of the main domain lysis, was developed. Screening for improved enantio-
and the cap domain and contains an Asp-His-Asp cata- selectivity of mutants was conveniently done using
lytic triad. This catalytic triad is conserved among epox- progress curve analysis of the conversion of a colorimet-
ide hydrolases and haloalkane dehalogenases [3]. The ric substrate. The epoxide hydrolase from A. radiobacter
active site of epoxide hydrolase further contains two has been well characterized, both structurally and kinet-
tyrosines located in the cap domain, which are involved ically [20, 21], and various active site mutants have been
in substrate binding and assist in the ring opening of described earlier [5, 6, 17, 19]. After error-prone PCR
the epoxide by acting as proton donor to the epoxide and recombination of the beneficial mutations by DNA
oxygen [4–6]. shuffling [22], mutants were obtained with 2- to 20-fold




quenced. This corresponds to an average of 2–3 amino
acid substitutions per mutant. The library of mutant
genes was cloned and expressed in E. coli. For expres-
sion, we used the pBAD system with which expression
can be dosed by adjusting the L-arabinose concentra-
tion and which appeared much more stable than the
pGEF expression system that we [23] and others [18]
used earlier.
The resulting library of around 40,000 colonies was
screened for activity toward 1,2-epoxybutane using an
agar plate assay with safranin O as an indicator of mem-Figure 1. Epoxide Substrates Used in This Study
brane potential (Figure 2A). This assay is based on the
1, styrene oxide; 2, meta-chlorostyrene oxide; 3, para-nitrostyrene
oxidation by E. coli of diols that are produced by epoxideoxide; 4, phenyl glycidyl ether; 5, para-nitrophenyl glycidyl ether; 6,
hydrolysis. NADH that is thereby generated causes anepichlorohydrin; 7, 1,2-epoxyhexane.
increase of the membrane potential due to the action
of the respiratory chain. The stronger proton gradient
Results that is generated enhances the uptake of safranin O and
its accumulation inside the cell, as was observed for
Error-Prone PCR Mutagenesis of EchA mitochondria [24]. E. coli colonies that possessed epox-
A library of random mutants of EchA was generated ide hydrolase activity obtained a rather uniform pink
using error-prone PCR. The conditions used in the PCR color due to accumulation of the dye, whereas inactive
reaction yielded 5–7 bp substitutions per gene, calcu- colonies had an uncolored outer ring. The test was veri-
fied with wild-type enzyme and various active and inac-lated from randomly picked mutants that were se-
Figure 2. Screening Procedure for Enhanced Enantioselectivity
(A) Activity screening of colonies using safranin O indicator plates.
(B) UV/VIS progress curves of pNPGE (5) conversion with whole cells in 96-well plates. Wells A6–D6 (red border) and A7–D7 (blue border)
represent wild-type controls and blank incubations, respectively.
(C) UV/VIS progress curves of pNPGE conversion by cell-free extract. The curve with E  3.4 was obtained with wild-type EchA. The curve
with E  32 was obtained with mutant S4 (Table 1). The curve with E  500 is a simulation that indicates the curve in case of perfect
enantioselectivity.
(D) Chiral HPLC analysis of a kinetic resolution of 0.5 mM racemic pNPGE. The example is mutant M5. (), (R )-pNPGE; (), (S )-pNPGE.
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tive mutants that were available from previous studies Table 1. Enantioselectivities toward pNPGE (5) of EchA Mutants
[5, 25]. By using the activity prescreening, the more time-
Mutant Mutationsa E-valuebconsuming screening for enantioselectivity could be re-
M1 A110G, K126E, E192G 4.3stricted to mutants that are active with at least one
M2 Y215F 9.1enantiomer of the racemic substrate. In this way, 78%
M3 L35M, H198L, C202S, H209R, D287E 12.0of the mutants turned out to be inactive. These mutants
M4 V112I, Y215F 11.0were excluded from the next step. The activity screening
M5 T31P, A110G, Y152F 14.0
yielded 8867 active clones (22%), which were grown M6 F108I, D122G 9.6
and stored in microtiter plates. M7 E7V, H106L, D131G, Q134L, D159E, E170G 7.5
M8 C172S, L277S 6.6The library of active clones was screened for improved
M9 Y214N 4.3cenantioselectivity by following the time course of the
M10 F66L, S121C, D200E 5.2conversion of a racemic mixture of para-nitrophenyl
M11 Y215H, Y251C 11.9glycidyl ether (pNPGE, epoxide 5 in Figure 1). Conver-
M12 I117T, F276Y 7.1
sion was monitored at 350 nm for 1 hr in a microtiter M13 D136V, Q154H, T227S, E271V, D287E 7.0
plate reader (Figure 2B). Around 70% of the selected M14 H198L 7.4
M15 C248Y 5.8mutants were active with pNPGE. The progress curves
WT – 3.4were subsequently analyzed as described under Experi-
S1 F108I, S121C, L277S 44mental Procedures. An increase in enantioselectivity
S2 Y152F, E170G, E271V, D287E 20was indicated by the presence of a bend in the progress
S3 F108I, S121C, D200E, Y215F 22
curve, which is not observed with the wild-type enzyme. S4 F108I, P205H, Y215H, E271V 32
Mutants with low activity and poor enantioselectivity S5 F108I, V112I, D159E, E170G, S184A, Y215F 26
S6 D131G, Q134L, Y152F, T227S, Y251C 27were discarded. This way, 112 mutants in which the
S7 A110G, Y152F, Y251C 19enantioselectivity was potentially increased were se-
S8 Y152F, D159E, E271V 21lected. Most of these mutants showed incomplete con-
F108I F108I 20version or a clearly biphasic conversion of racemic sub-
Y152F Y152F 20
strate. The selected mutants were grown in a larger Y215F Y215F 9.1
volume, and subsequently crude extracts of the cells Y215H Y215H 13
E271V E271V 2.9were used for recording spectrophotometric progress
curves of pNPGE hydrolysis with a normal cuvette. The Mutants M1 to M15 were selected after error-prone PCR; mutants
curves were again inspected for the presence of a sec- S1 to S8 were selected after DNA shuffling.
ond kinetic phase (Figure 2C), which yielded 45 mutants a Mutations shown in bold are part of the active site. Mutations that
are underlined were introduced during gene shuffling.that were selected for precise determination of their
b E-values were determined using 0.5 mM pNPGE as a substrate.E-value in a kinetic resolution of pNPGE. The progress
The data were fitted to competitive Michaelis-Menten kinetics ascurve data were fitted according to competitive Michae-
described before [26].
lis-Menten kinetics in a similar way as described before c Due to enzyme inactivation during the kinetic resolution, no appro-
[26] (Figure 2D). This does not result in unique solutions priate fit could be obtained. The E-value was calculated from the
for the kcat and Km values for both enantiomers, but the enantiomeric excess (% e.e.) and percentage of conversion at each
point.ratio between the kcat/Km values, which is the E-value,
is accurately obtained. Of the 45 mutants tested, 15
mutants showed a 1.5- to 4-fold improved enantioselec-
proved mutants were subjected to gene shuffling [22].tivity toward pNPGE as compared to wild-type EchA
For this, DNA from these mutants was randomly di-(Table 1).
gested and subsequently reassembled to the full-lengthSequence analysis of the 15 improved mutants
echA gene. The shuffled DNA was cloned and expressedshowed that the number of amino acid substitutions
in E. coli. This gave a library of about 20,000 clones,varied from 1 to 6 per mutant, with a total of 34 mutated
which were screened for activity toward 1,2-epoxybu-positions (Table 1). Using the X-ray structure of EchA
tane using the indicator plate assay. Screening of the(1EHY) [21], it appeared that 21 of the mutated positions
resulting 6952 active clones with the pNPGE progresswere located in the main domain, which contains 204
curve analysis method in microtiter plates yielded 86amino acids (residues 1–134 and 225–294). From these
potentially improved mutants. A further round of testing21 mutated positions, 13 were located at the top near
with cell-free extracts reduced the number to 44 possi-the interface with the cap domain, and 5 were located
ble candidates, which were used in a kinetic resolutionat the bottom (Figure 3A). Only 3 mutated residues were
of pNPGE. From this, 8 recombinants were obtainedlocated in the middle part of helices of the main domain
that had a 5.5- to 13-fold improved enantioselectivity(Figure 3A). The central part of the  sheet of the main
toward pNPGE as compared to wild-type (Table 1).domain was completely free of mutations.
Sequence analysis of the 8 mutants with the largestIn the cap domain, 13 positions out of 90 (residues
increase in enantioselectivity showed that 16 of the 34135–224) were mutated. These mutations were distrib-
positions that were present in the EchA mutants ob-uted all over the cap domain (Figure 3A).
tained by error-prone PCR were maintained in these
recombinants (Table 1). Also, two new mutations were
introduced during the shuffling procedure (Table 1). OfShuffling Mutants with Enhanced
Enantioselectivity the total 18 mutated positions, 11 were located in the
main domain, all on the C-terminal side of the catalyticIn order to recombine the beneficial mutations gener-
ated by the error-prone PCR, the genes of the 15 im- nucleophile D107 (Table 1; Figure 3B). The recombina-
Chemistry & Biology
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Figure 3. Positions of the Selected Mutations in the X-Ray Structure of EchA
(A), initial mutations selected after error-prone PCR; (B), mutations selected after recombination by gene shuffling. Blue/red, main domain,
/-hydrolase fold; green, cap domain; purple, active site aspartate; yellow, positions of the mutations. In (B), the radius of the sphere is
proportional to the frequency of the mutation in the final set of eight mutants.
tion thus resulted in a focusing of the mutations around Effect of Single-Site Mutations
In order to determine the effect on enantioselectivitythe active site of the enzyme (Figure 3B). Indeed, all
of the most frequently occurring mutations, five singlerecombinants contained at least one mutation of a resi-
mutants were constructed and their E-values were de-due that is part of the active site, replacing either one of
termined by performing kinetic resolutions (Table 1). Allthe tyrosines that is facilitating the epoxide ring opening
these single mutants, except for mutant E271V, showedduring the first catalytic step, or replacing F108, which
an increased enantioselectivity toward pNPGE. Theis located next to the catalytic nucleophile.
E-values of the shuffled mutants S2, S6, S7, and S8 were
similar to that of the Y152F single mutant (Table 1).
Characterization of the Improved Recombinants The enhanced enantioselectivity of mutant F108I to-
In order to characterize the recombinant epoxide hy- ward pNPGE was mainly due to a lower Km for the pre-
drolases with enhanced enantioselectivity, the enzymes ferred enantiomer, whereas in the wild-type the Km val-
were produced at a larger scale and purified as de- ues for both enantiomers are similar (Table 3). The kcat
scribed before [25]. The recombinant enzymes S1 and for both enantiomers has increased as compared to
S6 appeared unstable during purification and were not wild-type, but their difference has become somewhat
further characterized. The other purified mutant enzymes smaller. Mutants S1, S3, S4 and S5 have a higher enan-
were used to perform kinetic resolutions with seven differ- tioselectivity toward pNPGE than the single-site F108I
ent racemic epoxides (Figure 1). mutant (Table 1). Conversion of pNPGE with mutant
The results indicate a remarkable increase in enantio- F108I showed rapid hydrolysis of the (R )-enantiomer as
selectivity toward various epoxides besides pNPGE (5), soon as the preferred (S )-enantiomer was completely
the substrate that was used for screening (Table 2). All converted (Figure 4). This unwanted effect is absent in
mutants had an increased E-value for at least three other the four shuffling mutants containing this mutation, such
substrates. Furthermore, the change in enantioselec- as mutant S4 (Table 1; Figure 4). Thus, in this case the
tivity is largely dependent on the substrate used. The additional mutations in the four recombinants have an
recombinant enzymes containing the mutations in F108 additional positive effect.
and Y215 all showed a significant increase (2- to 20- In three of the mutants carrying the F108I substitution,
fold) in enantioselectivity toward styrene oxide (1) and Y215 is also mutated, either to phenylalanine or histidine.
epichlorohydrin (6). The recombinants containing the When tested separately, it appeared that the single-site
Y152F and/or the E271V mutation are significantly en- mutants Y215F and Y215H also have an increased enanti-
hanced (4- to 8-fold) in their enantioselectivity toward oselectivity toward pNPGE (Table 1). The Y215H mutant
para-nitrostyrene oxide (pNSO, 3) and 1,2-epoxyhexane showed a large increase in Km for both enantiomers
(7). The most remarkable increase in enantioselectivity (Table 3). The resulting kcat/Km was decreased more for
was observed for mutant S4, which showed 1.5- to 20- the slower reacting enantiomer than for the preferred
fold improvement of the enantioselectivity toward five (S )-enantiomer, resulting in enhanced enantioselectivity
(Table 3). The combination of mutations F108I andcompounds besides the selection substrate.
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Table 2. The Enantioselectivities of the Purified Improved Mutants toward the Various Epoxides
Enantioselectivity (E-Value), (Activitya (mol min1 mg1))
1 2 3 4 5 6 7
WT 16 (7.5) 5.7 (1.4) 56 (7.0) 12 (11) 3.4 (12) 2 (38) 3.6 (7.5)
S2 –b (0.6) –d (0.05) 193 (1.4) 25 (0.06) 20 (2.3) 2.6 (6.5) 23 (4.2)
S3 27 (1.5) 2.3 (1.0) 6.4 (1.3) 17 (0.04) 22 (3.9) 7.5 (18.2) 6.5 (2.8)
S4 50 (1.4) 4.6 (0.7) 81 (0.6) 15 (0.12) 32 (1.1) 40 (4.2) 27 (3.9)
S5 37 (0.8) 2.3 (0.6) 6.8 (1.0) 3.7 (0.04) 26 (3.1) 7.3 (7.7) 5.5 (2.9)
S7 –d (0.1) –d (0.05) 200 (0.6) 18 (0.01) 19 (1.1) 2.6 (2.3) 15 (0.8)
S8 –c (0.1) –d (0.05) 117 (0.6) 13 (0.03) 21 (1.1) 2 (2.1) 18 (1.5)
Substrate concentrations were 1 mM (epoxide 4), 2 mM (2, 3, and 5), or 5 mM (1, 6, and 7).
a Most values were measured at substrates below Km and therefore do not represent kcat values.
b Inactivation occurred during the reaction, resulting in incomplete conversion of the preferred enantiomer, which made the data not suited
to determine an accurate E-value.
c Activity too low to determine an accurate E-value.
d Activity was below the detection limit indicated.
Y215H in mutant S4 and of F108I and Y215F in S3 and progress curve analysis for the conversion of the chro-
mogenic substrate pNPGE in microtiter plates. TheS5 resulted in E-values that were higher than those of
all single mutants, indicating that also in this case the shape of the progress curves quickly indicates enantio-
selectivity. This method has the advantage that competi-effect of the mutations was additive (Table 1). In con-
trast, the enantioselectivity of recombinants S3 and S5 tive inhibition of one enantiomer on the conversion of
the other, which can be an important factor in enzymefor pNSO was lower than that of the separate F108I and
Y215F mutants, whereas recombinant S4 had an E-value enantioselectivity, is taken into account. Other colori-
metric screening methods for improved enantioselectiv-between that of the single mutants (Table 3) [5]. Thus,
for pNPGE (5) the active site mutations were additive, ity used the enantiomers in separate assays, which can
provide more accurate information on initial activitieswhereas for pNSO they were either antagonistic (S3 and
S5) or resulted in the average of the effect of the single- [27–29], but may overlook mutants in which the im-
proved enantioselectivity is mainly caused by increasedsite mutations (S4).
differences between Km values. The use of a kinetic
resolution of pseudo enantiomers followed by ESI-MSDiscussion
analysis also would include this inhibitory effect, since
it monitors the kinetic resolution of a (pseudo) racemicIn this paper, we show that directed evolution can be
used to improve the enantioselectivity of epoxide hy- mixture [18, 30, 31]. This method was recently used to
screen a random mutagenesis library of the epoxidedrolase from A. radiobacter toward several chiral epox-
ides. To make it possible to screen large libraries, we hydrolase from A. niger for improved enantioselectivity
toward phenyl glycidyl ether [18].used a new agar plate activity detection method for
initial selection of clones producing active enzyme. Sub- Six of the eight mutants that had an improved enantio-
selectivity with pNPGE also had enhanced enantioselec-sequently, the library of active clones was tested by
Table 3. Steady-State Kinetic Parameters and Enantioselectivities of EchA Variants for pNSO (3) and pNPGE (5)
(R )-pNSO (S )-pNSO (R )-pNPGE (S )-pNPGE
WT kcat (s1) 2.4 2.3 3.3 5.3
Km (mM) 0.007 0.5 0.03 0.03
kcat/Km (mM1 s1) 343 6.3 110 177
E-valuea 54 (56) 1.6 (3.4)
F108I kcat (s1) 4.5 2.5 11.2 12.3
Km (mM) 0.022 0.5 0.084 0.0043
kcat/Km (mM1 s1) 201 10.5 133 2859
E-valueb 19 (15) 22 (20)
Y215H kcat (s1) 1.0 0.006 0.1 1.9
Km (mM) 0.1 0.3 0.4 0.7
kcat/Km (mM1 s1) 4.6 0.027 0.33 4.1
E-valueb 168 (156) 12 (13)
S4 kcat (s1) 0.27 0.002 0.005 0.56
Km (mM) 0.5 0.5 0.25 0.25
kcat/Km (mM1 s1) 0.44 0.005 0.03 1.0
E-valueb 88 (81) 33 (32)
For several mutants, only lower limits could be determined for kcat, since the Km value exceeded the highest substrate concentration that
could be used because of low solubility and the strong absorbance of the substrate at high concentrations.




Figure 4. Kinetic Resolutions of pNPGE (5) with Wild-type EchA, Two Site-Directed Mutants, and Recombinant S4
(), (R )-pNPGE; (), (S )-pNPGE.
tivities toward other 1,2-epoxides. The substrate pNPGE discrimination is mainly present in the first two steps,
which are substrate binding and formation of the cova-was chosen for screening, since it gives a spectro-
photometric signal during conversion and might mimic lent intermediate, as was found earlier by pre-steady-
state kinetic analysis [20].1,2-epoxides with a flexible side group, such as epoxyal-
kanes or epihalohydrins. Because the highest improve- In the error-prone PCR mutants, the mutations were
mainly present at the interface of the main domain andments in enantioselectivity were indeed reached with
epichlorohydrin (6) and 1,2-epoxyhexane (7), this approach the cap domain (Figure 3A). The central  sheet of the
main domain was free of amino acid substitutions. Muta-was apparently working. Few E-values have been re-
ported for other epoxide hydrolases, but they can be tions in this region that would result in a large change
of the side group or introduce a charged group arecalculated from published data on the enantiomeric ex-
cess (% e.e.) and yield of the remaining epoxide [32, expected to have a destabilizing effect on the enzyme
[36], whereas mutations that cause small changes prob-33]. When compared with these calculated values, it
appeared that the mutants described here have higher ably do not alter stereospecificity. Recombination of the
beneficial mutations in the DNA shuffling round resultedenantioselectivity than other enzymes with styrene ox-
ide (1) [32, 33], pNSO (3) [34, 35], phenyl glycidyl ether in focusing of the mutations around the active site and
in  helix 3 (amino acids 108–122; Figure 3B). This (4) [18, 32], and epichlorohydrin (6) [32, 33]. For epichlor-
ohydrin, the shuffled mutant S4 has an E-value of 40, helix 3 directly follows the nucleophile elbow, and the
mutation could have an effect on the position of thewhich is more than 10-fold higher than the highest en-
antioselectivity described for this compound so far (E  nucleophilic aspartate D107.
In previous studies aimed at improving enantioselec-3.8, [33]).
In most cases, the enhanced enantioselectivity is due tivity of an enzyme, mutations were often found that
were located far away from the active site [18, 27–29].to a reduced kcat/Km for the nonpreferred enantiomer.
Several mutants showed a 2- to 10-fold decrease in The effects of these mutations were often small as com-
pared to the active site mutations that enhance enantio-conversion rate at the low substrate concentrations that
were used (Table 2). This is mainly due to an elevated selectivity we observed in EchA. In all eight shuffled
mutants with the highest enantioselectivity, one of theKm, since the kcat values were not much reduced for the
substrates for which they could be measured (Table active site residues is mutated. In seven out of these
eight shuffled mutants, a mutation occurred in one of3). Thus, at higher substrate concentrations, which are
more practically relevant, the activity will be reduced the tyrosines that assist in the epoxide ring opening by
acting as a proton donor (Table 1). Mutations that re-only a little. The enantioselectivity can improve without
significant loss of catalytic rate, since cleavage of the place one of the two tyrosines by a phenylalanine were
previously found to enhance enantioselectivity towardcovalent intermediate is the slowest step in the catalytic
cycle of A. radiobacter epoxide hydrolase [20]. Enantio- a number of aromatic epoxides [5, 17, 19].
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Two active site mutations that were not previously The enantioselectivity toward aliphatic substrates was
especially improved, which reflects the use of pNPGEfound are F108I and Y215H. In mutant Y215H, the histi-
dine probably does not act as a proton donor, since as a mimic of an aliphatic epoxide substrate. The mu-
tations were focused around the active site of thethe effect of the mutation on the enantioselectivity and
steady-state kinetics of the enzyme for pNSO is similar epoxide hydrolases and mainly affected residues in-
volved in epoxide ring opening. Since this is not theto that of mutation Y215F (Table 3) [5]. Mutation F108I
causes a large improvement in enantioselectivity toward slowest step in the catalytic cycle of the enzyme, en-
hanced enantioselectivity could be obtained in severalpNPGE, and also the catalytic rate is enhanced. The
improved selectivity is based on an increased difference mutants without loss of catalytic rate. The results con-
tribute to the development of a toolbox of engineeredbetween the Km values for the enantiomers (Table 3).
Previously, a W227F mutation was detected at this con- epoxide hydrolases for use in biocatalysis.
served position in microsomal epoxide hydrolase and
Experimental Proceduresappeared to influence stereoselectivity with glycidyl-
4-nitrobenzoate and phenantrene-9,10-oxide [37]. Resi-
Materialsdue F108 is located next to the active site nucleophile. Safranin O and para-nitrophenyl glycidyl ether (pNPGE, epoxide 5
Its main chain amide is part of the oxyanion hole, and in Figure 1) were purchased from Acros (Geel, Belgium). 1,2-epoxy-
the side group lines the substrate binding site [21]. An butane was from Merck. All other epoxides and other chemicals
were from Aldrich. All DNA-modifying enzymes and ampicilin werealtered position of the backbone amide thus is expected
purchased from Roche Molecular Biochemicals, except for Pwoto influence rate-limiting hydrolysis of the covalent inter-
DNA polymerase (GENAXIS GmbH), Pfu DNA polymerase (Stra-mediate, which can explain the observed increase in
tagene), and DpnI (New England Biolabs). L-arabinose was fromkcat. The enhanced enantioselectivity is likely due to an Lancaster (Frankfurt am Main, Germany). All other medium compo-
interaction between the substrate and the side group nents were from Merck and Difco. Plasmid vector pBADmycHisA
of residue 108. In directed evolution studies with lipases, and strain E. coli TOP10 were from Invitrogen. Oligonucleotides
were from Eurosequence BV and Sigma Genosys. The constructsthe enhanced enantioselectivity was often due to an
were sequenced at the Biomedical Center in Groningen using thealtered conformation of the oxyanion hole, resulting in
pBADmycHisA forward and reverse primer. The Chiralpak AS, Chi-improved conversion [38].
ralpak AS-H, and Chiralcel OD HPLC columns were from DiacelIt has been described that combination of mutations Chemical industries. The G-TA capillary GC column was from Astec.
can have additive effects in the case of thermostability
[39, 40] and enantioselectivity [28, 38]. With the EchA Construction of the Error-Prone PCR Mutant Library
mutants, two pronounced additive effects on enantiosel- Error-prone PCR of the epoxide hydrolase gene was carried out
to construct a mutant library, which could then be screened forectivity were also found. The kinetic resolution of pNPGE
enhanced enantioselectivity. The epoxide hydrolase gene from A.(5) by mutant F108I has the disadvantage that the re-
radiobacter AD1 [25] (echA, GenBank accession number Y12804)maining (R )-enantiomer is rapidly hydrolyzed after the
was cloned downstream of the L-arabinose-inducible araB promotor
preferred enantiomer is depleted. Fortunately, the intro- in pBADmycHisA using the forward primer BL035 (5-GAGCGCGC
duction of additional mutations overcomes this disad- CATGGCAATTCGACGTCCAGAAGAC-3) and reverse primer BL036
vantage and leads to mutants S3, S4, and S5, in which (5-GCGCGCCTGCAGCTAGCGGAAAGCGGTCTTTATTCG-3). The
restriction sites NcoI (forward) and PstI (reverse) that were usedthe remaining enantiomer is only slowly converted (Fig-
are underlined. The pBAD expression system, which we have usedure 4), which is due to an elevated Km and a greatly
previously [41], is more stable than the pGEF-based system thatreduced kcat/Km for the nonpreferred enantiomer (Table was used by Reetz et al. [18] and Bosma et al. [23]. Error-prone
3). In previous studies, it was shown that mutation Y215F PCR was performed using pBADEchA as a template and 0.4 nM
did not improve enantioselectivity toward the aliphatic primers BL035 and BL036, 0.2 mM dATP and GTP, 1 mM dCTP and
substrates epichlorohydrin (6) and 1,2-epoxyhexane (7) dTTP, and Taq buffer containing 5 mM MgCl2 and 0.2 mM MnCl2.
Taq DNA polymerase was used at a concentration of 0.025 U l1.[17], whereas the combined mutations in S3 and S5
The temperature program used was 4 min at 94	C followed by 30clearly do (Table 2). Thus, directed evolution can rapidly
cycles of 60 s 94	C, 45 s 58	C, and 70 s 72	C and finished with 4lead to recombinants in which different beneficial muta-
min at 72	C. The PCR product was digested with NcoI and PstI and
tions that enhance epoxide hydrolase enantioselectivity cloned into NcoI-PstI-digested pBADmycHisA using T4 DNA ligase.
are combined. The ligation mixture was transformed to E. coli TOP10 using electro-
poration.
Significance Site-Directed Mutagenesis
Site-directed mutants of EchA were made using the QuickChange
protocol from Stratagene. Primers used were as follows: F108IThe enantioselectivity of Agrobacterium radiobacter
sense, 5-CGTTGGCCATGAtaTCGCGGCCATCG-3; F108I anti-epoxide hydrolase toward para-nitrophenyl glycidyl
sense, 5-CGATGGCCGCGAtaTCATGGCCAACG-3; Y215H sense,
ether (pNPGE) and other epoxides could be improved 5-GGAGGCTTCAACTACcATCGTGCCAACATAAGG-3; Y215H anti-
by using directed evolution. This yielded a range of sense: 5-CCTTATGTTGGCACGAtgGTAGTTGAAGCCTCC-3; E271V
mutant enzymes with remarkably enhanced potential sense, 5-ACGATGGAGACGATCGtAGACTGCGGTCACTTC-3; E271V
antisense, 5-GAACTGACCGACGTCTaCGATCGTCTCCATCGT-3.for the kinetic resolution of epoxides. A rapid and sim-
The mutated codons are in bold, and introduced restriction sitesple agar plate screening was used for activity testing.
are underlined. Base pair substitutions are in lowercase.Spectrophotometric progress curve analysis with a ra-
cemic substrate was used to screen for enhanced en-
Construction of the Shuffled Library
antioselectivity. The progress curve analysis method Plasmid DNA from selected mutants was isolated and used as a
should be generally applicable to other enantioselec- template in a normal PCR reaction containing 0.2 mM dNTPs in
standard Pwo buffer and 0.025 U l1 Pwo DNA polymerase. Thetive reactions that give a chromogenic signal as well.
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primers and temperature program used were the same as for error- (DMSO) to a final concentration between 0.2 and 0.5 mM. The final
concentration of DMSO was less than 1% (v/v). A suitable amount ofprone PCR. Subsequently, a mixture of equal amounts of each PCR
product was treated for 45 s with 1.5 U ml1 DNase I in order to cell-free extract (CFE) was added to start the reaction. The resulting
curves were inspected for biphasic behavior, and the mutants thatcreate fragments of DNA that could then be recombined in a re-
assembly PCR. Fragments ranging from 100–250 bp were isolated were confirmed to be positive were selected for the next step in the
screening procedure.from a 2% agarose gel and subjected to a reassembly PCR without
primers, using 0.4 mM dNTPs and Pwo DNA polymerase. The tem-
perature program used was 30 s at 94	C, followed by 60 cycles of Spectrophotometric Epoxide Hydrolase Assays
60 s at 94	C, 45 s 58	C, 70 s 72	C, and finished by 10 min at 72	C. Steady-state kinetic parameters of purified wild-type and mutant
Reassembled DNA of around 0.9 kb was isolated from a 0.8% aga- epoxide hydrolases were determined by measuring progress curves
rose gel and used as a template in a normal PCR reaction in order of the conversion of enantiopure para-nitrostyrene oxide (pNSO, 3)
to restore the restriction sites in all reassembled fragments. The and pNPGE (5). Substrate was added up to a concentration of 0.5
reassembled genes were cloned into pBADmycHisA and trans- mM with a final concentration of DMSO lower than 1% (v/v). A
formed to E. coli by electroporation. suitable amount of purified protein was added to start the reaction.
These measurements were performed on a Kontron Uvikon 930 UV/
Agar Plate Assay for Epoxide Hydrolase Activity VIS spectrophotometer. The spectrophotometric substrate conver-
Transformed cells were put on agar plates containing 6 g l1 trypton, sion traces for the separate enantiomers of 3 were directly fitted to
3 g l1 yeast extract, 10 g l1 NaCl, 50 g ml1 ampicilin, 0.02% (w/v) Michaelis-Menten kinetics as described before [5]. The traces for
L-arabinose, and 100 M safranin O. Cells were grown overnight at both enantiomers of 5 were fitted in a similar fashion using the
30	C, followed by overnight incubation at room temperature. The extinction coefficients for epoxide 5 (
350 3993 M1 cm1) and the
plates were subsequently placed in a closed jar and exposed to 1,2- corresponding vicinal diol (
350 4572 M1 cm1).
epoxybutane vapor for 9 hr at room temperature and then incubated
overnight at room temperature in order to allow the cells to generate Kinetic Resolutions
excess NADH by oxidation of the vicinal diol formed as a result of The enantioselectivity of the mutants for various epoxides (Figure
epoxide hydrolysis. Inactive colonies had an unstained outer ring, 1) was determined by performing a kinetic resolution of 0.5–5 mM
whereas active colonies appeared as homogeneously purple colo- of racemic substrate in 8–20 ml of 100 mM Tris-SO4 (pH 9.0). Thenies. The positive colonies were used to inoculate 200 l Luria- reaction was started by adding a suitable amount of CFE or purified
Bertani (LB) medium with 10% (v/v) glycerol in 96-well plates. The enzyme, and samples were taken in time and extracted with hexane
inoculated plates were grown overnight at 30	C and stored at80	C. or ether containing an internal standard. If ether was used for extrac-
Expression of the mutant enzymes was achieved by duplicating the tion, the samples were dried on a short column of anhydrous MgSO4.storage library in 96-well plates containing LB medium with 0.02% The samples were analyzed using chiral HPLC and GC. The data
(w/v) L-arabinose, followed by overnight growth at 30	C. In all media, were fitted to competitive Michaelis-Menten kinetics as described
ampicillin was used at a concentration of 50 g ml1. before [26] in order to determine the E-value.
Screening for Improved Enantioselectivity Using
Chiral HPLC and GC AnalysisSpectrophotometric Progress Curve Analysis
For the analysis of the conversion of epoxides 1, 2, 6, and 7 (FigureThe E-value of a kinetic resolution can be estimated from the shape
1), a Chiraldex G-TA capillary GC column was used and mesityleneof a progress curve in which conversion of a racemic substrate is
or 1-chlorohexane was used as an internal standard. Epoxide 1:plotted against time. With low enantioselectivity, conversion can be
mesitylene, tr  3.0 min; (S )-1, tr  5.2 min; (R )-1, tr  5.9 min atfollowed to completion (curve with E  3.4 in Figure 2C). If the
110	C. Epoxide 2: mesitylene, tr  2.2 min; (S )-2, tr  8.0 min; (R )-2,conversion is perfectly enantioselective, a progress curve will dis-
tr  9.9 min with 7 min at 120	C; 5	C min1 to 150	C. Epoxide 6:play incomplete hydrolysis and the reaction stops at 50% conver-
1-chlorohexane, tr  3.0 min; (S )-6, tr  3.2 min; (R )-6, tr  3.4 minsion (see simulated curve with E 500 in Figure 2C). If enantioselec-
at 80	C. Epoxide 7: (S )-7, tr  5.7 min; (R )-7, tr  6.0 min; mesitylene,tivity is modest, two distinct kinetic phases are obtained, with a
tr  10.1 min at 60	C. The conversion of epoxides 3, 4, and 5 (Figurebend in the curve at around 50%–60% conversion, which is the result
1) was analyzed using various chiral HPLC columns with mesityleneof the difference between the kinetic parameters of the enzyme for
or para-nitroacteophenone as an internal standard. Epoxide 3: me-the two enantiomers (curve with E 32 in Figure 2C). If a colorimetric
sitylene, tr  3.0 min; (R )-3, tr  9.2 min; (S )-3, tr  12.6 min on asubstrate is used, a progress curve can be recorded using a spectro-
Chiralpak AS-H column with heptane:2-propanol 7:3 as the eluent.photometer, and the resulting curve is governed by the following
Epoxide 4: mesitylene, tr  3.1 min; (R )-4, tr  6.1 min; (S )-4, tr equation, which can be numerically integrated over time:
9.3 min on a Chiralcel OD column with heptane:2-propanol 4:1 as
the eluent. Epoxide 5: para-nitroacetophenone, tr  10.0 min; (S )-5,






S   RKmR  1*KmS

kcatR*Enz*R
R   SKmS  1*KmR
 . heptane:2-propanol 7:3 as the eluent. With all HPLC separations,
the flow rate was 1.0 ml min1.
The position of the bend and the initial and final rate of conversion
Protein Expression and Purificationprovide information about the enantioselectivity and kinetic proper-
Expression of EchA mutants was achieved by inoculating 3 liters ofties of the enzyme. To screen a large number of mutants for improved
LB medium containing 0.02% L-arabinose and 50 g ml1 ampicilinenantioselective behavior, a progress curve of the conversion of
with a 250 ml preculture without L-arabinose. The induced cells werepara-nitrophenyl glycidyl ether (pNPGE, epoxide 5 in Figure 1) for
grown overnight at room temperature. The cells were centrifugedeach mutant was recorded in a microtiter plate reader at 350 nm
and washed in 250 ml TEMAG (pH 7.5) at 4	C. A cell-free extract(
350epoxide  3993 M1 cm1, 
350diol  4572 M1 cm1). The initial rate
was made, and the protein was purified using DEAE-52 Sepharose(Vinit) and the final rate (Vterm) as well as the A350 at t  0 and t  60
anion exchange chromatography followed by a hydroxyapatite step,min were scored and used for evaluation. Progress curves showing
as described before [25].a high Vinit:Vterm ratio, combined with incomplete conversion of the
substrate, were expected to be biphasic and were inspected for the
presence of two distinct kinetic phases. Preparation of Epoxides
Epoxide 2 was synthesized from meta-chlorobenzaldehyde in theCell-free extracts made from cultures that were selected as candi-
dates with possibly improved enantioselectivity were used for mea- same way as para-chlorostyrene oxide was previously synthesized
from para-chlorobenzaldehyde [26]. The racemate of epoxide 3 wassuring progress curves at 350 nm in a normal cuvette. The measure-
ments were done in 100 mM Tris-SO4 (pH 9.0) at 30	C on a Perkin synthesized as described before [42]. (R )-3 and (S )-3 were obtained
by HPLC separation on a Chiralpak AS preparative column. (R )-5Elmer Lambda Bio 10 UV/VIS spectrophotometer. The substrate
was added from a stock solution of 25–50 mM in dimethyl sulfoxide and (S )-5 were synthesized from para-nitrophenol and (R )- or (S )-
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